MPO Antibody Polyclonal
| Catalog number: | A2010027 |
| Lot number: | Batch Dependent |
| Expiration date: | Batch Dependent |
| Package Size: | 0.5 mg |
| Other names: | Polyclonal antibody to human Myeloperoxidase (MPO) |
| Supplied as: | Solution |
| Concentration: | 1.0 mg/mL |
| Clonality: | Polyclonal |
| Host: | Rabbit |
| Specificity: | Human Myeloperoxidase (MPO) |
| Cross-reaction: | n/a |
| Purification: | Affinity Purified |
| Immunogen | High purity native human Myeloperoxidase |
| Preservative: | 0.05% sodium azide |
| Storage: | 2-8C (short term), -20C (long term). Avoid repeated freeze-thaw. |
References
- Myeloperoxidase. (2015). Encyclopedia of Immunotoxicology , 648648.
- Griffin, S. V., Chapman, P. T., Lianos, E. A., and Lockwood, C. M. (1999). The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney International , 55 (3), 917925.
- Furtmller, P. G., Obinger, C., Hsuanyu, Y., and Dunford, H. B. (2000). Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride ion. European Journal of Biochemistry , 267 (19), 58585864.
- Dawra, R., Ku, Y., Sharif, R., Dhaulakhandi, D., and Saluja, A. (2004). Myeloperoxidase Inhibitory Activity In Pancreas And LungA Simple Method For Its Removal And Extraction Of Myeloperoxidase. Pancreas , 29 (4), 362.
- Ichimori, K., Fukuyama, N., Nakazawa, H., Aratani, Y., Koyama, H., Takizawa, S., Suzuki, K. (2003). Myeloperoxidase has Directly-opposed Effects on Nitration ReactionStudy on Myeloperoxidase-deficient Patient and Myeloperoxidase-knockout Mice. Free Radical Research , 37 (5), 481489.
- Chen S, Chen H, Du Q, Shen J. Targeting Myeloperoxidase (MPO) Mediated Oxidative Stress and Inflammation for Reducing Brain Ischemia Injury: Potential Application of Natural Compounds. Front Physiol. 2020 May 19;11:433.
- Ndrepepa G. Myeloperoxidase A bridge linking inflammation and oxidative stress with cardiovascular disease. Clin Chim Acta. 2019 Jun;493:36-51.
- Manchanda K, Kolarova H, Kerkenpa C, Mollenhauer M, Vitecek J, Rudolph V, Kubala L, Baldus S, Adam M, Klinke A. MPO (Myeloperoxidase) Reduces Endothelial Glycocalyx Thickness Dependent on Its Cationic Charge. Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1859-1867.
- Variji A, Shokri Y, Fallahpour S, Zargari M, Bagheri B, Abediankenari S, Alizadeh A, Mahrooz A. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role? Atherosclerosis. 2019 Jan;280:7-13.
